Professional Documents
Culture Documents
From the Department of Medicine, Dr. Luke A. Neilans (Medicine): A 46-year-old woman was seen in the emergency de-
Brigham and Women’s Hospital (M.S.), partment at this hospital because of muscle pain and swelling in her arms and
the Departments of Radiology (C.C.W.)
and Pathology (A.L.), Massachusetts lower legs.
General Hospital, and the Departments The patient had been well until approximately 3 weeks before admission, when
of Medicine (M.S.), Radiology (C.C.W.), a deep ache developed in her left triceps, in the absence of trauma. During the fol-
and Pathology (A.L.), Harvard Medical
School — all in Boston. lowing weeks, the pain persisted, gradually spreading to both arms and both legs,
and was exacerbated by movement; she began having difficulty rising from chairs
N Engl J Med 2013;369:764-73.
DOI: 10.1056/NEJMcpc1208152 and climbing stairs because of pain. Two weeks before admission, examination by
Copyright © 2013 Massachusetts Medical Society. her primary care physician at another hospital reportedly revealed no focal muscle
weakness. Red-cell indexes and blood levels of electrolytes, calcium, and glucose
Paciente viene con dolor muscular e
hinchazón en sus brazos y piernas inferiores.were normal, as were renal-function tests; testing for parvovirus B19 IgG and IgM
antibodies was negative; other test results are shown in Table 1. Three days before
Tríceps izquierdo le empezó hace tres admission, pain and swelling in the left arm worsened. She returned to the other
semanas, sin trauma aparente, las hospital. Blood levels of alkaline phosphatase, direct and total bilirubin, total
siguientes semanas se expandió a ambos protein, albumin, and thyrotropin were normal, and testing for antibodies to the
brazos y ambas piernas.
human immunodeficiency virus and Borrelia burgdorferi were negative; other test
Dificultad para levantarse de las sillas y subir results are shown in Table 1. The patient returned home, with persistent symptoms.
escaleras Three days later, she came to the emergency department at this hospital.
The patient reported restricted range of motion of her arms because of pain, as
well as stiffness in her proximal arm muscles that was worse in the morning. She
also reported intermittent nondrenching night sweats that she attributed to meno-
pause. She reported no muscle weakness, fever, chills, malaise, dysphagia, nasal
regurgitation, synovitis, weight loss, numbness or tingling in her hands, shortness
of breath, chest pain, changes in bowel or bladder function, nausea, vomiting,
photosensitivity, or rash. A diagnosis of uterine fibroids with menorrhagia had
been made 2 years earlier. Routine mammograms had been normal. Her only
medication was megestrol acetate, taken midcycle (10 days per month). She had
no known allergies. She was single, physically active, and had traveled widely. She
drank alcohol in moderation, and she did not smoke or use illicit drugs. Her
mother had had breast cancer at age 65 years, and her father had had a myocar-
dial infarction at age 57 years. There was no family history of rheumatologic or
neuromuscular disorders.
* Reference values are affected by many variables, including the patient population and the laboratory methods used. The ranges used at Massa
chusetts General Hospital are for adults who are not pregnant and do not have medical conditions that could affect the results. They may
therefore not be appropriate for all patients.
On examination, the blood pressure was cose, calcium, phosphorus, magnesium, total pro-
113/82 mm Hg, the pulse 101 beats per minute, tein, albumin, globulin, alkaline phosphatase, di- PAN : 120/80
the temperature 36.7°C, the respiratory rate 18 rect and total bilirubin, and thyrotropin. Results of PULSO N: 60-100 lpm
breaths per minute, and the oxygen saturation renal-function tests were normal; other test results Resp N: 12-18 rpm
100% while the patient was breathing ambient are shown in Table 1. Urinalysis revealed positive
air. When she was standing, her pulse increased nitrites, 3+ ketones, and trace occult blood and
to 120 beats per minute, without symptoms of albumin; few bacteria, few squamous cells, and
dyspnea or light-headedness. Her voice was slightly very few transitional cells were seen per high-
gravelly, which she reported was unchanged. There power field. Screening of the urine for human Se descarta hCG y
was firm, nonpitting swelling and tenderness to chorionic gonadotropin (hCG) and toxins was toxinas
palpation on the right shoulder and from the left negative. Ultrasonography of the left arm and
shoulder to the hand. Both calves were tender to right leg showed no deep venous thrombosis.
palpation, without visible swelling. Gait and mus- Dr. Carol C. Wu: A chest radiograph showed a
cle strength were normal, and she could easily soft-tissue opacity, 9.0 cm by 9.0 cm by 12.4 cm,
squat, stand, and rise up on either foot on tiptoe. in the right lower hemithorax that obscured the
There was no rash, evidence of nail-bed infarcts, right heart border, with no evidence of pneumo-
or impairment of respiratory excursions; the re- nia or pulmonary edema (Fig. 1A). The opacity was
mainder of the examination was normal. seen anteriorly on the lateral view. The appearance
The activated partial-thromboplastin time was was suggestive of an anterior mediastinal mass.
normal, as were blood levels of electrolytes, glu- Computed tomography (CT) after the administra-
Differ en t i a l Di agnosis
Mass
Dr. Margaret Seton: I am aware of the diagnosis in
this case. This 46-year-old woman presented with
asymmetric swelling and pain in the arms, calf
pain, an elevated creatine kinase level, and a large
mediastinal mass. The patient was usually healthy,
worked as a journalist, and had traveled widely. She
described no cough, dyspnea, fever, or chest pain.
The rheumatology service was asked to see the
tion of intravenous contrast material (Fig. 1B and patient to address the question of myositis in
1C) confirmed the presence of a large, anterior this context. We were initially concerned about
mediastinal soft-tissue mass with a smooth mar- vascular compression, infection, or trauma, since
gin and heterogeneous density but with no evi- the predominant symptom was pain and the pre-
dominant finding was taut and swollen arms. the autoimmunity expressed in many patients with
Although the cardiac ultrasound examination thymomas.3
confirmed that the mass was compressing the
right atrium and causing turbulence in the right Myasthenia Gravis
pulmonary venous return, there was no frank The striking feature in most thymomas is the pref-
obstruction, no thrombosis, and no muscle in- erential targeting of autoantibodies to neuromus-
farction, and the neurovascular findings of com- cular end plates and other muscle antigens. The
partment syndrome were absent. most common paraneoplastic process in thymo-
ma is myasthenia gravis, an autoimmune disease
Polymyositis of the neuromuscular junction4 that occurs in
Tropical pyomyositis can be manifested as a fo- about 25% of patients with thymoma.3 In pa-
cal lesion in muscle, usually in association with tients with thymoma-associated myasthenia gra-
fever and antecedent trauma, or alternatively, in vis, acetylcholine receptor binding antibodies are
an immunocompromised or malnourished host. characteristically present; the antibody titers mark
These findings were not present in this case. the disease rather than correlate with clinical se-
Asymmetric muscle pain and swelling are not verity. Striated-muscle antibodies targeting pro-
typical manifestations of the inflammatory myop- teins found in both skeletal and cardiac muscle
athies. Rather, these myopathies are characterized are also present in some patients with thymoma
by symmetric and proximal-muscle weakness, and myositis.5,6 Polymyositis, giant-cell myocar-
difficulty swallowing, and sometimes dyspnea ditis, pure red-cell aplasia, hypogammaglobu-
(when the respiratory muscles become involved). linemia, and a spectrum of movement disorders
Idiopathic inflammatory myopathies may be para- spawned by antibodies that target muscle com-
neoplastic syndromes, may be associated with ponents are also described in cases of thymo-
distal neuromuscular weakness (e.g., inclusion- ma.5-12 Despite repeated questioning, this patient
body myositis), or may be accompanied by a pho- did not report symptoms attributable to myasthe-
tosensitive rash (e.g., dermatomyositis). Myalgias nia gravis. Instead, she reported symptoms of a
can occur but are usually mild, except in viral myositis.
myopathies.
Myositis
Thymoma The idiopathic inflammatory myopathies (derma-
The mediastinal mass in this case is highly sug- tomyositis, polymyositis, and inclusion-body my-
gestive of thymoma. Patients with thymoma may ositis) are rare.13 Polymyositis and giant-cell
be asymptomatic or may present with paraneo- myocarditis are the most commonly reported in-
plastic autoimmune disease or with chest pain flammatory myopathies associated with myas-
and vascular compression symptoms.1 In this case, thenia gravis or thymoma.7 Dermatomyositis is
vascular compromise did not account for the re- recognized in case reports of patients with thy-
gional muscle swelling and pain. Therefore, we moma or myasthenia gravis,14-18 but inclusion-
favored a diagnosis of a paraneoplastic manifes- body myositis has not been described in such re-
tation of thymoma, most likely a myositis that was ports. Patients with such myopathies classically
atypical in distribution. present with proximal-muscle weakness, dyspha-
Central immune tolerance is orchestrated in gia, and anterior neck muscle weakness; there is
the thymus through the selective deletion of ef- a well-known association with a malignant tumor,
fector T cells targeted to self-antigens. Precursors which is manifested either concurrently with the
of lymphocytes and dendritic cells home to the inflammatory myopathy or in the early years af-
thymus, where cortical epithelial cells promote ter its diagnosis and treatment.19-22 New antibod-
maturation and lineage commitment. Through ies defining idiopathic inflammatory myopathies
the expression of tissue self-antigens, enhanced are promising to change the diagnostic criteria
by the autoimmune regulator gene (AIRE), med- and redefine the clinical spectrum of these dis-
ullary thymic epithelial cells educate immune cells eases.23,24
to recognize self and to delete autoreactive T cells This patient presented with features consis-
before they leave the thymus.2 Failure to induce tent with an inflammatory myopathy. Our initial
this tolerance to self-antigens may account for concern was that she had a myopathy heralding
A B
C D
suggestive of type B1 thymoma; however, defini- dividual fibers, which suggested involvement by
tive classification is best based on the resected an immune-mediated activation of the complement
tumor. system (Fig. 3D). The morphologic and immuno-
A biopsy specimen of the left triceps muscle phenotypic features are consistent with a severe
was obtained. The muscle was described as “un- destructive inflammatory myopathy and exten-
usually firm” at the time of biopsy. On micro- sive monophasic muscle injury resulting in wide-
scopical examination, the muscle was markedly spread degeneration and regeneration of muscle
cellular; extensive fibrosis between muscle fas- fibers.
cicles and the surrounding individual myofibers Dr. Seton: After the needle-biopsy results indi-
was highlighted by a trichrome stain (Fig. 3B). cated a diagnosis of thymoma, pulse therapy with
In contrast to normal muscle fibers, these fibers methylprednisolone sodium succinate was admin-
were smaller, more basophilic, and rounded, and istered for 3 consecutive days, followed by oral
many had multiple nuclei that were centrally lo- prednisone. I would like to ask the patient how
cated within the fiber, features consistent with she felt after the first infusion of intravenous
severe muscle injury and regeneration (Fig. 3A). glucocorticoids.
A lymphohistiocytic infiltrate was present between The Patient: I felt instantly better. Not just “not
muscle fibers. Immunohistochemical stains re- worse,” but better. I felt as though I could have
vealed focal large aggregates of CD68+ macro- run up 52 flights of stairs at the Prudential Center.
phages and CD3+ T cells surrounding individual Dr. Seton: Two weeks after the biopsy, the patient
muscle fibers (Fig. 3C). Deposition of a stain for was readmitted for resection of the thymoma.
membrane-attack complex appeared around in- Dr. Louissaint: The resected anterior mediasti-
A B
C D
nal mass consisted of an enlarged thymus with resection specimen could represent type A (med-
a well-encapsulated, firm, ovoid, white-pink mass, ullary) thymoma, or possibly type AB (mixed) or
10.2 cm in diameter, on its inferior aspect (Fig. type B1 (lymphocytic) thymoma with lympho-
4A). The mass had a tan, nodular cut surface with cyte depletion due to therapy; a definite subclas-
focal yellow areas, corresponding to necrosis sification of the thymoma could not be deter-
(Fig. 4B). Microscopical examination revealed a mined. There was focal microscopical capsular
predominance of oval or spindle-shaped, keratin- invasion, and all margins and lymph nodes were
positive epithelial cells with a marked decrease negative for involvement.
in the lymphocytic component (Fig. 4C and 4D) Dr. Seton: This patient presented initially with Mitosis:
as compared with the initial biopsy specimen. an asymmetric, necrotizing myositis that was muerte
Flow cytometry did not reveal immature T cells. rapidly followed by the evolution of symptoms of muscular
Immunohistochemical stains for CD1a and TdT myasthenia gravis, which became life-threaten- dolor y
showed only occasional cortical thymocytes ing. The myositis led to muscle death, pain, and contractura
(Fig. 4E and 4F). contractures; the myasthenia gravis led to dete-
It is possible that the marked reduction in the rioration in speech, swallowing, and vision. Miastenia:
lymphoid component is related to the glucocor- Additional testing showed high titers of ace- Deterioro
ticoid therapy, which causes rapid loss of corti- tylcholine receptor antibodies, acetylcholine re-
del habla,
visión,
cal thymocytes. The pathological findings in the ceptor modulating antibodies, and antibodies to
deglución
A B
C D
E F
striated muscle (1:983,040; reference range, <1:60). the stiff person syndrome), or antibodies ac-
The patient did not have antibodies to MuSK, counting for other disorders of neurologic trans-
voltage-gated potassium channel (seen in neuro- mission.
myotonia), glutamic acid decarboxylase (seen in This patient’s prognosis, on the basis of the
WHO classification of either type A or type B1 Dr. Seton: I do think that is an astonishing
and complete surgical resection, is excellent; part of this case. However, in many autoimmune
patients with thymoma and myasthenia gravis diseases, autoantibodies may be present in a
may have better outcomes than patients who have patient’s blood for years before the onset of symp-
thymoma without myasthenia gravis.28 Clinically, toms, and the event that results in end-organ
the patient has improved dramatically. She has damage is unclear.
regained function in terms of caliber of voice,
restoration of vision, swallowing, and muscle A NAT OMIC A L DI AGNOSIS
strength. The administration of pyridostigmine
and glucocorticoids was tapered and discontin- Inflammatory myopathy and myasthenia gravis
ued. Mild residual flexion contractures in her associated with thymoma.
hands and left foot remain, as does left phrenic-
This case was presented at the medical case conference.
nerve palsy as a consequence of the surgery. Al- No potential conflict of interest relevant to this article was re-
though second malignant tumors are described ported.
in the literature in patients with thymoma, this Disclosure forms provided by the authors are available with
the full text of this article at NEJM.org.
patient is currently well and will be followed We thank Drs. Donald Bloch, E. Tessa Hedley-Whyte, and
conservatively during the next several years.29 Robert P. Hasserjian for their comments and review of an earlier
Dr. Hasan Bazari (Medicine): It seems likely that version of the manuscript; and Drs. William David (Neurology),
Michael Lanuti (Surgery), Emily Hyle (Medicine), and Andrew
this tumor had been present for some time. How Liteplo (Emergency Medicine) for their assistance with prepa-
can we explain the abrupt onset and fulminant ration of the case history.
progression of the patient’s symptoms?
References
1. Case Records of the Massachusetts 10. Montes LF, Ceballos R, Cooper MD, matomyositis and polymyositis. Intern Med
General Hospital (Case 16-2007). N Engl J Bradley MN, Bockman DE. Chronic mu- 1999;38:81-2.
Med 2007;356:2185-93. cocutaneous candidiasis, myositis, and 18. Rundle LG, Sparks FP. Thymoma and
2. Boehm T, Bleul CC. Thymus-homing thymoma: a new triad. JAMA 1972; dermatomyositis: a disease entity. Arch
precursors and the thymic microenviron- 222:1619-23. Pathol 1963;75:276-83.
ment. Trends Immunol 2006;27:477-84. 11. Mygland A, Vincent A, Newsom-Davis 19. Buchbinder R, Forbes A, Hall S, Den-
3. Kelly RJ, Petrini I, Rajan A, Wang Y, J, et al. Autoantibodies in thymoma-asso- nett X, Giles G. Incidence of malignant
Giaccone G. Thymic malignancies: from ciated myasthenia gravis with myositis or disease in biopsy-proven inflammatory
clinical management to targeted thera- neuromyotonia. Arch Neurol 2000;57: myopathy: a population-based cohort
pies. J Clin Oncol 2011;29:4820-7. 527-31. study. Ann Intern Med 2001;134:
4. Conti-Fine BM, Milani M, Kaminski 12. Suzuki S, Utsugisawa K, Nagane Y, et 1087-95.
HJ. Myasthenia gravis: past, present, and al. Classification of myasthenia gravis 20. Fine RM. The Fine page: risk of cancer
future. J Clin Invest 2006;116:2843-54. based on autoantibody status. Arch Neu- in patients with dermatomyositis. Int J
5. Skeie GO, Romi F, Aarli JA, Bentsen rol 2007;64:1121-4. Dermatol 1993;32:22.
PT, Gilhus NE. Pathogenesis of myositis 13. Oddis CV, Ascherman D. Clinical fea- 21. Sigurgeirsson B, Lindelöf B, Edhag O,
and myasthenia associated with titin and tures, classification and epidemiology of Allander E. Risk of cancer in patients with
ryanodine receptor antibodies. Ann N Y inflammatory muscle disease. In: Hoch- dermatomyositis or polymyositis: a popu-
Acad Sci 2003;998:343-50. berg MC, Silman AJ, Smolen JS, Weinblatt lation-based study. N Engl J Med 1992;
6. Somnier FE, Engel PJ. The occurrence ME, Weisman MH, eds. Rheumatology. 26:363-7.
of anti-titin antibodies and thymomas: a 5th ed. Philadelphia: Mosby Elsevier, 22. Stockton D, Doherty VR, Brewster
population survey of MG 1970-1999. Neu- 2011:1439-55. DH. Risk of cancer in patients with der-
rology 2002;59:92-8. 14. Shichijo K, Mitsui T, Kunishige M, matomyositis or polymyositis, and fol-
7. Aarli JA. Inflammatory myopathy in Kuroda Y, Masuda K, Matsumoto T. In- low-up implications: a Scottish popula-
myasthenia gravis. Curr Opin Neurol volvement of mitochondria in myasthenia tion-based cohort study. Br J Cancer
1998;11:233-4. gravis complicated with dermatomyositis 2001;85:41-5.
8. Geary CG, Byron PR, Taylor G, MacIver and rheumatoid arthritis: a case report. 23. Dalakas MC. Immunopathogenesis of
JE, Zervas J. Thymoma associated with pure Acta Neuropathol 2005;109:539-42. inflammatory myopathies. Ann Neurol
red cell aplasia, immunoglobulin deficiency 15. van de Warrenburg BP, Hengstman 1995;37:Suppl 1:S74-S86.
and an inhibitor of antigen-induced lympho- GJ, Vos PE, Boerman RH, ter Laak HJ, van 24. Mimori T, Imura Y, Nakashima R, Yo-
cyte transformation. Br J Haematol 1975;29: Engelen BG. Concomitant dermatomyosi- shifuji H. Autoantibodies in idiopathic
479-85. tis and myasthenia gravis presenting with inflammatory myopathy: an update on
9. Masuda M, Arai Y, Okamura T, Wada respiratory insufficiency. Muscle Nerve clinical and pathophysiological signifi-
M, Mizoguchi H. Pure red cell aplasia 2002;25:293-6. cance. Curr Opin Rheumatol 2007;19:
(PRCA) with thymoma: a possible distinct 16. Ago T, Nakamura M, Iwata I, et al. 523-9.
clinical entity distinct from large granu- Dermatomyositis associated with invasive 25. Travis WD, Brambilla E, Müller-Her-
lar lymphocyte (LGL) leukemia. Am J He- thymoma. Intern Med 1999;38:155-9. melink HK, Harris CC, eds. Pathology
matol 2000;63:102. 17. Nagasawa K. Thymoma-associated der and genetics of tumours of the lung, pleu-
ra, thymus and heart. Lyon, France: IARC 27. Marx A, Hohenberger P, Hoffmann H, sis of clinical and pathologic outcomes of
Press, 2004. et al. The autoimmune regulator AIRE in thymoma surgery. Ann Thorac Surg
26. Ströbel P, Murumägi A, Klein R, et al. thymoma biology: autoimmunity and be- 2010;89:245-52.
Deficiency of the autoimmune regulator yond. J Thorac Oncol 2010;5:Suppl 4:S266- 29. Welsh JS, Wilkins KB, Green R, et al.
AIRE in thymomas is insufficient to elicit S272. Association between thymoma and sec-
autoimmune polyendocrinopathy syndrome 28. Margaritora S, Cesario A, Cusumano ond neoplasms. JAMA 2000;283:1142-3.
type 1 (APS-1). J Pathol 2007;211:563-71. G, et al. Thirty-five-year follow-up analy- Copyright © 2013 Massachusetts Medical Society.
Lantern Slides Updated: Complete PowerPoint Slide Sets from the Clinicopathological Conferences
Any reader of the Journal who uses the Case Records of the Massachusetts General Hospital as a teaching exercise or reference
material is now eligible to receive a complete set of PowerPoint slides, including digital images, with identifying legends,
shown at the live Clinicopathological Conference (CPC) that is the basis of the Case Record. This slide set contains all of the
images from the CPC, not only those published in the Journal. Radiographic, neurologic, and cardiac studies, gross specimens,
and photomicrographs, as well as unpublished text slides, tables, and diagrams, are included. Every year 40 sets are produced,
averaging 50-60 slides per set. Each set is supplied on a compact disc and is mailed to coincide with the publication of the
Case Record.
The cost of an annual subscription is $600, or individual sets may be purchased for $50 each. Application forms for the current
subscription year, which began in January, may be obtained from the Lantern Slides Service, Department of Pathology,
Massachusetts General Hospital, Boston, MA 02114 (telephone 617-726-2974) or e-mail Pathphotoslides@partners.org.